Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: A Canadian perspective
- 1 November 2006
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 28 (11) , 1922-1934
- https://doi.org/10.1016/j.clinthera.2006.11.017
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The burden of neuropathic pain: results from a cross‐sectional surveyEuropean journal of pain, 2006
- The economic burden of neuropathic pain in CanadaJournal of Medical Economics, 2006
- Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic NeuropathyThe Clinical Journal of Pain, 2002
- Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research databaseFamily Practice, 2002
- Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow upBMJ, 2000
- Managing painful diabetic neuropathy.Hospital Practice, 1999
- Neuropathic pain: aetiology, symptoms, mechanisms, and managementThe Lancet, 1999
- The Epidemiology of Diabetic NeuropathyDiabetic Medicine, 1993
- Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications StudyDiabetes, 1989
- The Prevalence of Symptomatic, Diabetic Neuropathy in an Insulin-treated PopulationDiabetes Care, 1985